CD163 and cancer: In fact, numerous studies have revealed that the expression of M-CSF in tumor microenvironment is closely correlated with the number of CD163-positive M2 Mφs, which in turn contributes to the progression of several cancers, most likely by enhancing angiogenesis (97–99).